Why the study?
Does intravenous theophylline improve working capacity in patients with ischaemic heart disease and stable angina?
Does intravenous theophylline improve working capacity in patients with ischaemic heart disease and stable angina?
Intravenous theophylline significantly improves exercise tolerance and reduces ST depression in patients with stable angina.
Answers are grounded in this paper and cite their sources.
Intravenous theophylline improves exercise tolerance in stable angina; confirms benefit for working capacity in ischaemic heart disease.
The effect of theophylline on the working capacity of patients with ischaemic heart disease was evaluated in a double-blind, randomized cross-over study. Eight patients, receiving no medication, with stable effort-provoked angina pectoris and typical exercise-induced ST depressions were studied. Following intravenous administration of theophylline or placebo, the patients did a supine leg exercise limited by intolerable chest pain. The workload was continuously increased by 10 W/min. Following theophylline treatment the workload at the onset of chest pain increased from 71 +/- 9 to 114 +/- 14 W (P less than 0.002). The ST depression was less pronounced following theophylline at submaximal exercise (-0.01 +/- 0.00 vs. -0.09 +/- 0.02 mV, P less than 0.005, at 70 W). The maximum tolerable workload increased from 129 +/- 15 after placebo infusion to 153 +/- 12 W after theophylline infusion P less than 0.01). It is speculated that this beneficial effect of the adenosine receptor antagonist theophylline may possibly be due to inhibition of a pathophysiological coronary steal induced by elevated levels of adenosine during ischaemia.
No takes yet. Share an insight, caveat, or question.
Edlund et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: